Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Company Profile CNS Pharmaceuticals Inc. CNSP

CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma.


Company Profile & Information (NDAQ:CNSP)

Showcase News Releases

Showcase news

Prospera Energy Inc
Prospera Energy Inc. Announces Milestone Q2 2022 Revenue (Increase of 860% over Q2 2021)
Saturn Oil & Gas Inc.
Saturn Oil & Gas Inc. Reports Q2 2022 Financial and Operational Results Highlighted by Record Quarterly Cash Flow
Siyata Mobile Inc.
Siyata Mobile Announces Second Quarter 2022 Financial Results

More Showcase News Releases »